Medtronic plc. (MDT)
| Market Cap | 174.28B |
| Revenue (ttm) | 31.60B |
| Net Income (ttm) | 3.88B |
| Shares Out | 1.35B |
| EPS (ttm) | 2.86 |
| PE Ratio | 45.37 |
| Forward PE | 22.99 |
| Dividend | $2.37 (1.83%) |
| Ex-Dividend Date | Jun 24, 2021 |
| Volume | 6,833,296 |
| Open | 130.36 |
| Previous Close | 130.92 |
| Day's Range | 129.17 - 130.83 |
| 52-Week Range | 97.46 - 135.89 |
| Beta | 0.81 |
| Analysts | Buy |
| Price Target | 145.56 (+12.2%) |
| Est. Earnings Date | Nov 23, 2021 |
About MDT
Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. It operates through four segments: Cardiovascular Portfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; AF ablation products; insertable cardiac monitor systems; mechanical circulatory support; TYRX product...
Financial Performance
In 2021, Medtronic's revenue was $30.12 billion, an increase of 4.16% compared to the previous year's $28.91 billion. Earnings were $3.61 billion, a decrease of -24.70%.
Financial StatementsAnalyst Forecast
According to 27 analysts, the average rating for Medtronic stock is "Buy." The 12-month stock price forecast is 145.56, which is an increase of 12.23% from the latest price.
News
2 Top Healthcare Stocks to Buy Right Now
Both of these stocks are healthcare leaders and they're trading at reasonable valuations.
Medtronic's (MDT) Pilot Plan to Address SCA Care Disparities
Medtronic's (MDT) pilot program offers an advanced and scalable method to use real-world clinical data which enable quicker and appropriate care for patients at-risk of SCA.
U.S. Patent and Trademark Office Rejects Axonics' Challenge to Medtronic Patents
DUBLIN, Sept. 13, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has won three additional important victories in a dispute over its intellectu...
Medtronic Collaboration with Mpirik to Address Disparities in Care Associated with Sudden Cardiac Arrest
DUBLIN, Sept. 13, 2021 /PRNewswire/ -- Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced a pilot program with Mpirik to address disparities in care associated with the ...
Medtronic's (MDT) Emprint Ablation System Study Data Positive
Medtronic's (MDT) Emprint Ablation Catheter Kit received Breakthrough Device Designation status from the FDA in April 2021 and is currently in development.
Medtronic Executives to Speak at Upcoming Investor Conferences
DUBLIN, Sept. 7, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate virtually in the following upcoming investor conferences: 202...
Medtronic Announces NAVABLATE Study Results Released in Late-Breaking Podium Presentation at European Respiratory Soc...
Results Demonstrate Feasibility of Bronchoscopic Microwave Ablation for Certain Patients with Malignant Lung Nodules DUBLIN, Sept. 7, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in ...
Why Medtronic's Latest Quarterly Results Weren't as Good as They Might Seem
The healthcare giant posted strong growth. But there's more to the story.
7 Healthcare Stocks to Buy Before $3.5 Trillion Floods In
Covid-19 showed us how rapid advances in medicine and technology could create significant growth opportunities for healthcare stocks. The post 7 Healthcare Stocks to Buy Before $3.5 Trillion Floods In ...
Is This Medical-Device-Making Dividend Aristocrat a Buy?
Medtronic met analysts' consensus revenue estimate and exceeded earnings forecasts in the first quarter of its fiscal 2022.
Axonics: Buy at the High?
Axonics' stock price just hit its 52-week high, but its momentum means it's unlikely to last.
BetterInvesting™ Magazine Selects Medtronic as "Growth" Stock and D.R. Horton as "Undervalued" For November 2021 Issue
TROY, Mich., Sept. 1, 2021 /PRNewswire/ -- The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Medtronic PLC (NYSE: MDT) as its "Stock to Study" and D.R.
Best Buy Continues to Impress; Medtronic Hits a New High
A look at stock market news.
Medtronic's (MDT) Micra TPS CED Study Outcome Favorable
Medtronic's (MDT) Micra TPS new study data supports the relationship of a lower risk of complications with leadless pacing.
Medtronic Shares Real-World Data For Micra Leadless Pacemaker
Medtronic Plc (NYSE: MDT) touted data demonstrating reductions in reinterventions and complications with its Micra pacemaker. Medtronic's Micra Coverage with Evidence Development (CED) study showed that...
Real-World Data Demonstrate Significant Reduction in Complications and Reinterventions with Medtronic Micra Leadless ...
Results Presented at ESC 2021 Show Micra TPS Compares Favorably to Traditional Pacemakers DUBLIN, Aug. 27, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today a...
Is There More Room For Growth In Medtronic Stock?
Medtronic recently reported its fiscal Q1 2022 results, which were better than our estimates. The company reported revenues of $8.0 billion, slightly above ours and the consensus estimate of $7.9 billion.
Wednesday Afternoon Analyst Upgrades and Downgrades: Applied Materials, Best Buy, Intuit, Medtronic, Toll Brothers an...
The markets were higher across the board near midday, after a strong two-day rally opened the trading week.
Medtronic (MDT) Receives FDA Nod for Evolut FX TAVR System
Medtronic's (MDT) Evolut FX TAVR system offers hemodynamic and durability benefits of the Evolut platform with new product and procedure enhancements.
Why Medtronic Stock Popped Today
Medtronic "beat earnings" in Q1 -- and plans to keep on doing that all year long.
Medtronic Wins FDA Approval Of Next-Gen TAVR System For Aortic Stenosis
The FDA has approved Medtronic plc's (NYSE: MDT) Evolut FX TAVR system, a self-expanding transcatheter aortic valve replacement (TAVR) system. The Evolut FX system incorporates the same supra-annular v...
The Delta variant will be ‘short lived,' Medtronic CEO says
Karen Parkhill, Medtronic CFO, joins Yahoo Finance Live to discuss the company's strong first-quarter financial results and break down how the company continues to advance their cardiac monitoring and A...
Medtronic CEO on earnings, revenue beat and raised outlook
Medtronic chairman and CEO Geoffrey Martha joins CNBC's "Squawk on the Street" to discuss earnings and outlook.
Medtronic's (MDT) Q1 Earnings Beat Estimates, Margins Up
Medtronic's (MDT) fiscal first-quarter results reflect a strong recovery from the impact of the COVID-19 pandemic on elective procedures that the company experienced in 2020.